Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-02-010494
Filing Date
2002-03-19
Accepted
2002-03-19 00:00:00
Documents
4
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K405 a2068760z10-k405.htm 10-K405 597328
3 EXHIBIT 10.13 a2068760zex-10_13.txt EX-10.13 21219
4 EXHIBIT 21.2 a2068760zex-21_2.txt EX-21.2 269
5 EXHIBIT 23.1 a2068760zex-23_1.txt EX-23.1 513
  Complete submission text file 0000912057-02-010494.txt   621079
Mailing Address 350 4243 GIANFORD AVENUE VICTORIA, BRITISH COLUMBIA, CANADA
Business Address 350 4243 GLANFORD AVE VICTORIA BC CAN V8Z A1 2507442811
STRESSGEN BIOTECHNOLOGIES CORP (Filer) CIK: 0001064990 (see all company filings)

Type: 10-K405 | Act: 34 | File No.: 333-12570 | Film No.: 02578735
SIC: 2836 Biological Products, (No Diagnostic Substances)